Pulmonology
From the Journals
Mild COVID-19 infection linked to later type 2 diabetes
Results point to the need to monitor blood glucose following SARS-CoV-2 infection.
News from the FDA/CDC
FDA approves generic Symbicort for asthma, COPD
From the Journals
Analysis questions tocilizumab in ventilated COVID patients
Statistical review of earlier meta-analysis supports use of arthritis drug in hospitalized patients on non-invasive respiration.
News from the FDA/CDC
Legionnaires’ disease shows steady increase in U.S. over 15+ years
News from the FDA/CDC
CDC issues new pneumococcal vaccine recommendations for adults
PCV15 and PREVNAR20 received approval from the FDA in July 2021, providing an impetus for the revised recommendations.
From the Journals
Pediatric community-acquired pneumonia: 5 days of antibiotics better than 10 days
“These data are immediately applicable to frontline clinicians,” said Dr. Derek Williams of Vanderbilt University.
Feature
COVID-vaccine myocarditis: Rare, mild, and usually in young men
Should myocarditis be a concern as mRNA-based COVID-19 vaccines are authorized in ever-younger age groups?
News
COVID-19 linked to increased diabetes risk in youth
Two large databases indicate significantly increased diabetes risk among those with COVID-19 but not other acute respiratory illnesses.
From the Journals
Frail COPD patients at high risk of disability and death
But frailty did not significantly predict mortality in women, while dyspnea did not significantly predict mortality in men.
News
FDA backs Pfizer booster for 12- to 15-year-olds
The agency also shortened the recommended time between a second dose and the booster to 5 months or more,
News
FDA OKs emergency use of Merck pill for COVID-19
Similar to FDA authorization of another antiviral pill regimen granted to Pfizer, molnupiravir should be taken early in the course of COVID-19...